Learn

Sessions include:

• Analysis of Tissues at Single-cell Level with 3D Imaging Mass Cytometry
• Artificial Intelligence in Drug Discovery: Combining Clinical and Genomic Data from Cancer Patients to Identify Genetic Biomarkers and Potential Novel Targets
• Autonomous Robotic Search System for Biological Experiments on Regenerative Medicine Using Humanoid Robot
• Compound Management: Delivering ‘Solutions’
• Computer-aided Biology: DoE Solutions
• Deciphering OMICs Data Using AI
• Integration of Image Profiling and ‘Omics Platforms in Drug Discovery
• Okomera: Droplet Microfluidics to Automate Microtumor Formation and Screening for Precision Cancer Medicine
• Production and Biophysical Characterisation of Recombinant Proteins for FBDD
• The Tipping Point: Lab Sustainability and Future of Single-use Plastic
• Ultrasonically Actuated Portable Microfluidic Platform Delivers Uniform Aerosol Droplets with Tuneable Diameters

If you are interested in this track, you may also be interested in the following SLAS APPLIED content:

• Genome Editing Applications in Drug Discovery and Target Validation
• AI 101
• High-Content Imaging for Drug Discovery: Insights from Assay Design to Primary Models

Or, check out these related New Matter: Inside the Minds of SLAS Scientist podcast episodes:

• The State of What Is - A Lesson in Mass Spectrometry with Michelle Dubuke, Ph.D.
• Compound Management Made Easy with Jean Marois and Chatura Jayakody (Sponsored by Scigilian)

Sessions include:

• A Molecular and Computational Toolbox to Enable Therapeutic A-to-I RNA Editing
• Accelerating Precision Medicine - Turning Data into Insights Using AI and Automation
• Artificial Intelligence and Automation Enabling Rapid, Widely Available Autologous CAR-T Cell Therapy
• Design and Screening of Therapeutic Antisense Oligonucleotides (ASOs) Development of Direct to biology platform for rapidly evaluating PROTACs for targeted protein degradation
• High Throughout Mass Spectrometry (HTMS), combining Acoustic Ejection MS Innovation and Efficient
• Assay Development & Screening Capabilities to Accelerate?Drug Discovery
• Meeting the Gene Editing Potential of Cell Line Engineering with Image Analysis, Abstraction and Automation
• Mining the Functional Degradome with Unbiased PROTIENi Screening
• Novel Technologies for Development of Safer Therapeutic Genome Editing Medicines
• Personalized Medicine: A Technical Challenge for GMP Manufacturing of mRNA

If you are interested in this track, you may also be interested in the following SLAS APPLIED content:

• Phenotypic Screening and Target Deconvolution Micro-Credential
• Genome Editing Applications in Drug Discovery and Target Validation
• Drug Targeting RNA
• Patient Derived Scaffolds (PDS) in Cancer Research and Drug Discovery
• Biologics as Drug Therapy

Sessions include:

• Creating Patent Strategies in Europe
• Establishing Disruptive Innovation Capabilities: Creating Options for Future Business Expansion
• Evolution of The European Lead Factory: Towards Global Positioning of a Unique Library for Drug Discovery
• Evotec BRIDGEs: Pre-seed Funding to Accelerate Academic Drug Discovery
• Innovation and IP Management Panel Discussion
• Patent & Product Life Cycle Management
• Shaping a Patent Portfolio That Works for You
• What it Means for Scientists to Work with Deeptech Venture Capital Fund: Case of Aper Ventures

If you are interested in this track, you may also be interested in the following New Matter: Inside the Minds of SLAS Scientists podcast episodes:

• An Exploration in Cell Imaging and Photonic Innovation with Roland Terborg, Ph.D.
• Do Good for the World | Career Trajectories with Aoi Senju
• Discovering Clues for Success | Career Trajectories with Alison Hirukawa, Ph.D.

Or, check out related SLAS APPLIED content: SLAS Ignite Showcase 2021

Access Now